¥ 1821.5
Key Takeaways
Risk factor
Strong trading liquidity
Profitability factor
Favourable analyst view
About
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r
Target Price
The average target price of 6869.T is 2580 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
